These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

378 related articles for article (PubMed ID: 31392412)

  • 1. The basis of cellular and regional vulnerability in Alzheimer's disease.
    Mrdjen D; Fox EJ; Bukhari SA; Montine KS; Bendall SC; Montine TJ
    Acta Neuropathol; 2019 Nov; 138(5):729-749. PubMed ID: 31392412
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Molecular properties underlying regional vulnerability to Alzheimer's disease pathology.
    Grothe MJ; Sepulcre J; Gonzalez-Escamilla G; Jelistratova I; Schöll M; Hansson O; Teipel SJ;
    Brain; 2018 Sep; 141(9):2755-2771. PubMed ID: 30016411
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Integrative network analysis of nineteen brain regions identifies molecular signatures and networks underlying selective regional vulnerability to Alzheimer's disease.
    Wang M; Roussos P; McKenzie A; Zhou X; Kajiwara Y; Brennand KJ; De Luca GC; Crary JF; Casaccia P; Buxbaum JD; Ehrlich M; Gandy S; Goate A; Katsel P; Schadt E; Haroutunian V; Zhang B
    Genome Med; 2016 Nov; 8(1):104. PubMed ID: 27799057
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Regional vulnerability in Alzheimer's disease: The role of cell-autonomous and transneuronal processes.
    Acosta D; Powell F; Zhao Y; Raj A
    Alzheimers Dement; 2018 Jun; 14(6):797-810. PubMed ID: 29306583
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Greater Regional Cortical Thickness is Associated with Selective Vulnerability to Atrophy in Alzheimer's Disease, Independent of Amyloid Load and APOE Genotype.
    Li C; Duara R; Loewenstein DA; Izquierdo W; Cabrerizo M; Barker W; Adjouadi M;
    J Alzheimers Dis; 2019; 69(1):145-156. PubMed ID: 30958345
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of apolipoprotein E on biomarkers of amyloid load and neuronal pathology in Alzheimer disease.
    Vemuri P; Wiste HJ; Weigand SD; Knopman DS; Shaw LM; Trojanowski JQ; Aisen PS; Weiner M; Petersen RC; Jack CR;
    Ann Neurol; 2010 Mar; 67(3):308-16. PubMed ID: 20373342
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The FAS gene, brain volume, and disease progression in Alzheimer's disease.
    Erten-Lyons D; Jacobson A; Kramer P; Grupe A; Kaye J
    Alzheimers Dement; 2010 Mar; 6(2):118-24. PubMed ID: 19766542
    [TBL] [Abstract][Full Text] [Related]  

  • 8. HYDRA: Revealing heterogeneity of imaging and genetic patterns through a multiple max-margin discriminative analysis framework.
    Varol E; Sotiras A; Davatzikos C;
    Neuroimage; 2017 Jan; 145(Pt B):346-364. PubMed ID: 26923371
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neocortical origin and progression of gray matter atrophy in nonamnestic Alzheimer's disease.
    Phillips JS; Da Re F; Dratch L; Xie SX; Irwin DJ; McMillan CT; Vaishnavi SN; Ferrarese C; Lee EB; Shaw LM; Trojanowski JQ; Wolk DA; Grossman M
    Neurobiol Aging; 2018 Mar; 63():75-87. PubMed ID: 29223682
    [TBL] [Abstract][Full Text] [Related]  

  • 10. OCIAD1 contributes to neurodegeneration in Alzheimer's disease by inducing mitochondria dysfunction, neuronal vulnerability and synaptic damages.
    Li X; Wang L; Cykowski M; He T; Liu T; Chakranarayan J; Rivera A; Zhao H; Powell S; Xia W; Wong STC
    EBioMedicine; 2020 Jan; 51():102569. PubMed ID: 31931285
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Progressive regional atrophy in normal adults with a maternal history of Alzheimer disease.
    Honea RA; Swerdlow RH; Vidoni ED; Burns JM
    Neurology; 2011 Mar; 76(9):822-9. PubMed ID: 21357834
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A Review of Brain Atrophy Subtypes Definition and Analysis for Alzheimer's Disease Heterogeneity Studies.
    Zhang B; Lin L; Wu S
    J Alzheimers Dis; 2021; 80(4):1339-1352. PubMed ID: 33682711
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Aluminum involvement in the progression of Alzheimer's disease.
    Walton JR
    J Alzheimers Dis; 2013; 35(1):7-43. PubMed ID: 23380995
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neuropathologic basis of in vivo cortical atrophy in the aphasic variant of Alzheimer's disease.
    Ohm DT; Fought AJ; Rademaker A; Kim G; Sridhar J; Coventry C; Gefen T; Weintraub S; Bigio E; Mesulam MM; Rogalski E; Geula C
    Brain Pathol; 2020 Mar; 30(2):332-344. PubMed ID: 31446630
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pathway-Specific Genetic Risk for Alzheimer's Disease Differentiates Regional Patterns of Cortical Atrophy in Older Adults.
    Caspers S; Röckner ME; Jockwitz C; Bittner N; Teumer A; Herms S; Hoffmann P; Nöthen MM; Moebus S; Amunts K; Cichon S; Mühleisen TW
    Cereb Cortex; 2020 Mar; 30(2):801-811. PubMed ID: 31402375
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Anatomically-distinct genetic associations of APOE epsilon4 allele load with regional cortical atrophy in Alzheimer's disease.
    Filippini N; Rao A; Wetten S; Gibson RA; Borrie M; Guzman D; Kertesz A; Loy-English I; Williams J; Nichols T; Whitcher B; Matthews PM
    Neuroimage; 2009 Feb; 44(3):724-8. PubMed ID: 19013250
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Alzheimer's disease is not "brain aging": neuropathological, genetic, and epidemiological human studies.
    Nelson PT; Head E; Schmitt FA; Davis PR; Neltner JH; Jicha GA; Abner EL; Smith CD; Van Eldik LJ; Kryscio RJ; Scheff SW
    Acta Neuropathol; 2011 May; 121(5):571-87. PubMed ID: 21516511
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cortical distribution of neurofibrillary tangles in Alzheimer's disease matches the pattern of neurons that retain their capacity of plastic remodelling in the adult brain.
    Arendt T; Brückner MK; Gertz HJ; Marcova L
    Neuroscience; 1998 Apr; 83(4):991-1002. PubMed ID: 9502241
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Aging and Alzheimer's disease pathology.
    Sengoku R
    Neuropathology; 2020 Feb; 40(1):22-29. PubMed ID: 31863504
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The morphologic and neurochemical basis of dementia: aging, hierarchical patterns of lesion distribution and vulnerable neuronal phenotype.
    Hof PR; Giannakopoulos P; Vickers JC; Bouras C; Morrison JH
    Rev Neurosci; 1995; 6(2):97-124. PubMed ID: 8564027
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.